HERPESVIRUS VACCINES: Development, Controversies, and Applications
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 13 (1) , 61-81
- https://doi.org/10.1016/s0891-5520(05)70043-x
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 DiseaseThe Journal of Infectious Diseases, 1997
- Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccineThe Journal of Pediatrics, 1995
- Virologic Characteristics of Subclinical and Symptomatic Genital Herpes InfectionsNew England Journal of Medicine, 1995
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- A Seroepidemiologic Survey of the Prevalence of Herpes Simplex Virus Type 2 Infection in the United StatesNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Acquisition of Genital Herpes from an Asymptomatic Sexual PartnerNew England Journal of Medicine, 1986
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986
- Viremia is present in incubation period in nonimmunocompromised children with varicellaThe Journal of Pediatrics, 1985
- Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 1982